Evidence map›Paper›PMID 23292894›Full record

ArticleJournal of clinical laboratory analysis2013

Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis.

Mehmet Celikbilek, Serkan Dogan, Omer Ozbakır, Gökmen Zararsız, Hamit Kücük, Sebnem Gürsoy, Alper Yurci, Kadri Güven, Mehmet Yücesoy

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04558658 (Evaluation of Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease in Assiut University Hospitals), which is not on this map. Cited by 117 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 5 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04558658 unknown statusnot on this mapstarted 2020, after this paper: background citation

Evaluation of Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease in Assiut University Hospitals

Typeobservational_patient_registrySponsorAssiut UniversityRan2020 to 2022Enrolled50ConditionsInflammatory Bowel DiseasesArmsComplete Blood Count
3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 5 syntheses or guidelines pooled it, 262 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comorbid ADHD and Pediatric Sickle Cell Disease: Prevalence and Risk Factors.Journal of clinical psychology in medical settings · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mehmet CelikbilekDepartment of Gastroenterology and Hepatology, Erciyes University, Medical School, Kayseri, Turkey. drcelikbilek@yahoo.com
Serkan Dogan
Omer Ozbakır
Gökmen Zararsız
Hamit Kücük
Sebnem Gürsoy
Alper Yurci
Kadri Güven
Mehmet Yücesoy
Erciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood neutrophil-to-lymphocyte (N/L) ratio is an indicator of the overall inflammatory status of the body, and an alteration in N/L ratio may be found in ulcerative colitis (UC) patients. The aims of this study were to investigate the utility of N/L ratio as a simple and readily available predictor for clinical disease activity in UC.

methodsTwenty-six patients and 28 healthy controls were enrolled in the study. The neutrophil and lymphocyte counts were recorded, and the N/L ratio was calculated from these parameters. The extent of disease classified according to the Montreal classification, clinical disease activity was evaluated using a modified Truelove-Witts severity index, and endoscopic disease activities were classified according to Schroder et al.

resultsThe serum N/L ratios of active patients were significantly higher than those of inactive UC and controls (P < 0.001). The optimum N/L ratio cut-off point for active UC was 2.47. There was no significant difference between inflammation parameters, disease extension, and disease activity.

conclusionOur results demonstrate that N/L ratio is higher in patients with active UC compared with controls and UC patients in remission and a cut-off value of 2.47 can be used to identify patients with active ulcerative colitis.

Indexed as

AdultBiomarkersCase-Control StudiesColitis, UlcerativeFemaleHumansInflammationLeukocyte CountLymphocytesMaleMiddle AgedNeutrophilsPredictive Value of TestsROC CurveSeverity of Illness IndexStatistics, NonparametricBiomarkers

Identifiers

PMID23292894
PMCPMC6807407
OpenAlexW2096054692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.